#DCGI – Asian Mirror

March 15, 2023 by: web admin

DCGI approves radiological and nuclear emergency drugs developed by DRDO

ANS: Drugs Controller General of India has issued permits to Scott-Edil Pharmacia Ltd in Himachal Pradesh and Skanttr Lifescience in Gujarat to produce and sell …

April 27, 2022 by: web admin

DCGI node for COVID-19 vaccines for 5-12 years children

ANS: Drugs Controller General of India (DCGI), India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat …

February 22, 2022 by: web admin

DCGI grants EUA to Corbevax for children between 12-18 years

ANS: Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group. With …

January 5, 2022 by: web admin

Intranasal vaccine gets nod for Phase 3 trials in India

ANS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on …

August 20, 2021 by: web admin

DCGI approves DNA-based vaccine ZyCoV-D (three-dose vaccine) for Emergency Use Authorization

ANS: Drug Controller General of India (DCGI) has given nod to ZyCoV-D vaccine— indigenous developed Zydus Cadila COVID-19 vaccine for Emergency Use Authorization. In a …

July 1, 2021July 1, 2021 by: web admin

Moderna gets government nod for emergency use in India

ANS: The Drugs Controller General of India (DCGI), granted permission of the Emergency Use Authorisation (EUA) of Moderna’s COVID-19 vaccine in India on Tuesday. The …

May 14, 2021May 15, 2021 by: web admin

2-DG drug for treatment of COVID-19 patients to be launched next week

ANS: DRDO’s drug 2-Deoxy-D-Glucose is expected to be launched next week for the COVID patients, informed an official on Friday. The drug has been developed …

May 9, 2021May 9, 2021 by: web admin

DCGI approves anti-COVID oral drug for emergency use

ANS: The Drugs Controller General of India (DCGI) has given approval for emergency use to an oral drug, developed by the Defence Research and Development …

April 13, 2021 by: web admin

Sputnik V : India approves third Corona vaccine for emergency use

ANS: India got third vaccine— Sputnik V, against Coronavirus, after Covishield (the Oxford-Astrazeneca vaccine manufactured by the Serum Institute of India) and Covaxin (manufactured by …

December 5, 2020 by: web admin

Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine

ANS: Zydus Cadila Pharmaceuticals has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy …

From 156 Dishes to 15,000 Rakhis – Inside Khan Sir’s Grand Raksha Bandhan

From 156 Dishes to 15,000 Rakhis – Inside Khan Sir’s Grand Raksha Bandhan

Tag: #DCGI

DCGI approves radiological and nuclear emergency drugs developed by DRDO

DCGI node for COVID-19 vaccines for 5-12 years children

DCGI grants EUA to Corbevax for children between 12-18 years

Intranasal vaccine gets nod for Phase 3 trials in India

DCGI approves DNA-based vaccine ZyCoV-D (three-dose vaccine) for Emergency Use Authorization

Moderna gets government nod for emergency use in India

2-DG drug for treatment of COVID-19 patients to be launched next week

DCGI approves anti-COVID oral drug for emergency use

Sputnik V : India approves third Corona vaccine for emergency use

Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine